OpenAI is beginning to turn its attention to ‘superintelligence’
OpenAI CEO Sam Altman said that he believes OpenAI knows how to build AGI — and is beginning to turn its aim to ...
Pharmaceutical Technology52m
Osemitamab by Transcenta for Lung Cancer: Likelihood of Approval
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...